Personalis Inc (PSNL)
3.38
-0.08
(-2.31%)
USD |
NASDAQ |
Nov 21, 16:00
3.32
-0.06
(-1.78%)
Pre-Market: 09:10
Personalis Enterprise Value: 96.78M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 96.78M |
| November 20, 2024 | 102.44M |
| November 19, 2024 | 118.69M |
| November 18, 2024 | 111.62M |
| November 15, 2024 | 132.82M |
| November 14, 2024 | 161.78M |
| November 13, 2024 | 193.57M |
| November 12, 2024 | 227.48M |
| November 11, 2024 | 205.58M |
| November 08, 2024 | 179.44M |
| November 07, 2024 | 163.19M |
| November 06, 2024 | 252.21M |
| November 05, 2024 | 256.45M |
| November 04, 2024 | 211.23M |
| November 01, 2024 | 217.59M |
| October 31, 2024 | 214.77M |
| October 30, 2024 | 224.66M |
| October 29, 2024 | 220.37M |
| October 28, 2024 | 223.19M |
| October 25, 2024 | 190.70M |
| October 24, 2024 | 189.99M |
| October 23, 2024 | 189.29M |
| October 22, 2024 | 189.99M |
| October 21, 2024 | 194.94M |
| October 18, 2024 | 202.00M |
| Date | Value |
|---|---|
| October 17, 2024 | 184.34M |
| October 16, 2024 | 195.64M |
| October 15, 2024 | 202.00M |
| October 14, 2024 | 180.81M |
| October 11, 2024 | 192.11M |
| October 10, 2024 | 206.95M |
| October 09, 2024 | 214.72M |
| October 08, 2024 | 226.02M |
| October 07, 2024 | 218.96M |
| October 04, 2024 | 224.61M |
| October 03, 2024 | 199.18M |
| October 02, 2024 | 198.47M |
| October 01, 2024 | 206.24M |
| September 30, 2024 | 238.03M |
| September 27, 2024 | 259.49M |
| September 26, 2024 | 255.54M |
| September 25, 2024 | 222.57M |
| September 24, 2024 | 234.44M |
| September 23, 2024 | 249.27M |
| September 20, 2024 | 293.78M |
| September 19, 2024 | 306.31M |
| September 18, 2024 | 279.27M |
| September 17, 2024 | 289.16M |
| September 16, 2024 | 279.27M |
| September 13, 2024 | 290.48M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-114.38M
Minimum
Jun 17 2022
1.792B
Maximum
Jan 20 2021
251.10M
Average
124.33M
Median
Apr 01 2020
Enterprise Value Benchmarks
| Repligen Corp | 7.680B |
| Axogen Inc | 599.25M |
| CareDx Inc | 970.20M |
| Perspective Therapeutics Inc | -63.40M |
| Electromed Inc | 223.55M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -39.09M |
| Revenue (Quarterly) | 25.71M |
| Total Expenses (Quarterly) | 40.09M |
| EPS Diluted (Quarterly) | -0.64 |
| Gross Profit Margin (Quarterly) | 34.02% |
| Profit Margin (Quarterly) | -152.0% |
| Earnings Yield | -49.70% |
| Normalized Earnings Yield | -47.80 |